279 related articles for article (PubMed ID: 18705771)
41. Case report combined hepatocellular and cholangiocarcinoma with sarcomatous transformation.
Boonsakan P; Thangnapakorn O; Tapaneeyakorn J; Kositchaiwat S; Bunyaratvej S
J Med Assoc Thai; 2007 Mar; 90(3):574-80. PubMed ID: 17427538
[TBL] [Abstract][Full Text] [Related]
42. Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report.
Soeda J; Yazaki M; Nakata T; Miwa S; Ikeda S; Hosoda W; Iijima M; Kobayashi K; Saheki T; Kojiro M; Miyagawa S
J Clin Gastroenterol; 2008 Aug; 42(7):855-60. PubMed ID: 18385606
[TBL] [Abstract][Full Text] [Related]
43. A case with intrahepatic double cancer: hepatocellular carcinoma and cholangiocarcinoma associated with multiple von Meyenburg complexes.
Kim YW; Park YK; Park JH; Lee J; Lee SM; Hong SW; Yang MH
Yonsei Med J; 1999 Oct; 40(5):506-9. PubMed ID: 10565264
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathologic study on cholangiolocellular carcinoma.
Shiota K; Taguchi J; Nakashima O; Nakashima M; Kojiro M
Oncol Rep; 2001; 8(2):263-8. PubMed ID: 11182037
[TBL] [Abstract][Full Text] [Related]
45. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
Watanabe M; Akagi S; Hamamoto S
Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
[No Abstract] [Full Text] [Related]
46. [Diffuse bile duct papillomatosis: high rate of recurrence and risk of malignant transformation].
Brönnimann S; Zimmermann A; Baer HU
Chirurg; 1996 Jan; 67(1):93-7. PubMed ID: 8851683
[TBL] [Abstract][Full Text] [Related]
47. Characteristics of sarcomatous cholangiocarcinoma of the liver.
Shimada M; Takenaka K; Rikimaru T; Hamatsu T; Yamashita Y; Kajiyama K; Taguchi K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2000; 47(34):956-61. PubMed ID: 11020857
[TBL] [Abstract][Full Text] [Related]
48. Cholangiocarcinoma occurring in a liver with multiple bile duct hamartomas (von Meyenburg complexes).
Röcken C; Pross M; Brucks U; Ridwelski K; Roessner A
Arch Pathol Lab Med; 2000 Nov; 124(11):1704-6. PubMed ID: 11079031
[TBL] [Abstract][Full Text] [Related]
49. Lymphoepithelioma-like cholangiocarcinoma not associated with EBV.
Adachi S; Morimoto O; Kobayashi T
Pathol Int; 2008 Jan; 58(1):69-74. PubMed ID: 18067645
[TBL] [Abstract][Full Text] [Related]
50. Malignant Transformation in Von-Meyenburg Complexes: Histologic and Immunohistochemical Clues With Illustrative Cases.
Parekh V; Peker D
Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):607-14. PubMed ID: 25789533
[TBL] [Abstract][Full Text] [Related]
51. Bile duct adenoma and von Meyenburg complex-like duct arising in hepatitis and cirrhosis: pathogenesis and histological characteristics.
Aishima S; Tanaka Y; Kubo Y; Shirabe K; Maehara Y; Oda Y
Pathol Int; 2014 Nov; 64(11):551-9. PubMed ID: 25329860
[TBL] [Abstract][Full Text] [Related]
52. Cholangiocarcinoma arising in von Meyenburg complexes.
Kim HK; Jin SY
Korean J Hepatol; 2011 Jun; 17(2):161-4. PubMed ID: 21757989
[No Abstract] [Full Text] [Related]
53. Intrahepatic cholangiocarcinoma metastatic to the ovary: a report of 16 cases of an underemphasized form of secondary tumor in the ovary that may mimic primary neoplasia.
Khunamornpong S; Siriaunkgul S; Suprasert P; Pojchamarnwiputh S; Na Chiangmai W; Young RH
Am J Surg Pathol; 2007 Dec; 31(12):1788-99. PubMed ID: 18043033
[TBL] [Abstract][Full Text] [Related]
54. Intrahepatic sarcomatoid cholangiocarcinoma: clinical analysis of seven cases during a 15-year period.
Tsou YK; Wu RC; Hung CF; Lee CS
Chang Gung Med J; 2008; 31(6):599-605. PubMed ID: 19241900
[TBL] [Abstract][Full Text] [Related]
55. Resected case of a double cancer, a hepatocellular carcinoma and a cholangiocellular carcinoma, and their spread to the skin.
Suzuki H; Kuwano H; Masuda N; Hashimoto S; Saitoh T; Kanoh K; Nomoto K; Shimura T
Hepatogastroenterology; 2003; 50(50):362-5. PubMed ID: 12749221
[TBL] [Abstract][Full Text] [Related]
56. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
[TBL] [Abstract][Full Text] [Related]
57. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
Hunt JP; Varnholt H
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
[No Abstract] [Full Text] [Related]
58. Portal thrombosis due to intrahepatic cholangiocarcinoma following successful treatment for hepatocellular carcinoma.
Uenishi T; Hirohashi K; Haba T; Wakasa K; Kubo S; Shuto T; Tanaka H; Yamamoto T; Tanaka S; Kinoshita H
Hepatogastroenterology; 2003; 50(52):1140-2. PubMed ID: 12845999
[TBL] [Abstract][Full Text] [Related]
59. Combined hepatocellular-cholangiocarcinoma presented with massive pulmonary embolism.
Koskinas J; Betrosian A; Kafiri G; Tsolakidis G; Garaziotou V; Hadziyannis S
Hepatogastroenterology; 2000; 47(34):1125-8. PubMed ID: 11020895
[TBL] [Abstract][Full Text] [Related]
60. Intrahepatic cholangiocarcinoma and portal hypertension developing in a patient with multicystic biliary microhamartomas.
Sugawara T; Shindoh J; Hoshi D; Hashimoto M
Malays J Pathol; 2018 Dec; 40(3):331-335. PubMed ID: 30580365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
